Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometryDE ALBUQUERQUE CAVALCANTI, Gustavo; CARIUS GARRIDO, Bruno; DIAS LEAL, Felipe et al.Journal of steroid biochemistry and molecular biology. 2011, Vol 127, Num 3-5, pp 248-254, issn 0960-0760, 7 p.Article

A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulationVALLE, Marta; DI SALLE, Enrico; JANNUZZO, Maria Gabriella et al.British journal of clinical pharmacology. 2005, Vol 59, Num 3, pp 355-364, issn 0306-5251, 10 p.Article

Synthesis of exemestane labelled with ¹³CFONTANA, Erminia; PIGNATTI, Alberto; GIRIBONE, Danilo et al.Steroids. 2008, Vol 73, Num 7, pp 760-764, issn 0039-128X, 5 p.Article

Detection of new urinary exemestane metabolites by gas chromatography coupled to mass spectrometryALBUQUERQUE CAVALCANTI, Gustavo De; CARIUS GARRIDO, Bruno; DIAS LEAL, Felipe et al.Steroids. 2011, Vol 76, Num 10-11, pp 1010-1015, issn 0039-128X, 6 p.Article

The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal womenJANNUZZO, Maria Gabriella; POGGESI, Italo; SPINELLI, Riccardo et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 6, pp 475-481, issn 0344-5704, 7 p.Article

Compliance, Analgesic Use and Side-effect Protection within a German Cohort of the TEAM TrialBOSSART, Michaela; BECKER, Meike; HADJI, Peyman et al.Anticancer research. 2012, Vol 32, Num 9, pp 3933-3938, issn 0250-7005, 6 p.Article

Binding features of steroidal and nonsteroidal inhibitorsYANYAN HONG; RASHID, Rumana; SHIUAN CHEN et al.Steroids. 2011, Vol 76, Num 8, pp 802-806, issn 0039-128X, 5 p.Conference Paper

Characterization of the weak estrogen receptor α agonistic activity of exemestaneMASRI, Selma; KI LUI; PHUNG, Sheryl et al.Breast cancer research and treatment. 2009, Vol 116, Num 3, pp 461-470, issn 0167-6806, 10 p.Article

Bioequivalence of exemestane in post-menopausal femalesGROENEWOUD, Gerhard; NELL, Andre; POTGIETER, Linda et al.Arzneimittel-Forschung. 2010, Vol 60, Num 2, pp 96-100, issn 0004-4172, 5 p.Article

1,2-Dehydrogenation of steroidal 6-methylen derivatives. Synthesis of exemestaneMARCOS-ESCRIBANO, Andrés; BERMEJO, Francisco A; LORENTE BONDE-LARSEN, Antonio et al.Tetrahedron (Oxford. Print). 2009, Vol 65, Num 36, issn 0040-4020, 7325, 7587-7590 [5 p.]Article

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancerCHOW, Louis Wing-Cheong; YIP, Adrian Yun-San; LOO, Wings Tjing-Yung et al.Journal of steroid biochemistry and molecular biology. 2008, Vol 111, Num 1-2, pp 13-17, issn 0960-0760, 5 p.Article

Exémestane et hormonthérapies adjuvantes : perspectivesLUPORSI, Elisabeth.La Lettre du cancérologue (Boulogne). 2008, Num DEC, pp 4-6, issn 1165-113X, 3 p., NSArticle

Aromatase destabilizer : Novel action of exemestane, a food and drug administration-approved aromatase inhibitorXIN WANG; SHIUAN CHEN.Cancer research (Baltimore). 2006, Vol 66, Num 21, pp 10281-10286, issn 0008-5472, 6 p.Article

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerCOOMBES, R. Charles; HALL, Emma; COATES, Alan S et al.The New England journal of medicine. 2004, Vol 350, Num 11, pp 1081-1092, issn 0028-4793, 12 p.Article

Exemestane experience in breast cancer treatmentLØNNING, P. E; PARIDAENS, R; THÜRLIMANN, B et al.Journal of steroid biochemistry and molecular biology. 1997, Vol 61, Num 3-6, pp 151-155, issn 0960-0760Conference Paper

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane StudyBLISS, Judith M; KILBURN, Lucy S; DE VELDE, Cornelis J. H. Van et al.Journal of clinical oncology. 2012, Vol 30, Num 7, pp 709-717, issn 0732-183X, 9 p.Article

Severe prolonged cholestatic hepatitis caused by exemestaneTING BAO; FETTING, John; MUMFORD, Laura et al.Breast cancer research and treatment. 2010, Vol 121, Num 3, pp 789-791, issn 0167-6806, 3 p.Article

Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisationFALLOWFIELD, L. J; KILBURN, L. S; LANGRIDGE, C et al.British journal of cancer. 2012, Vol 106, Num 6, pp 1062-1067, issn 0007-0920, 6 p.Article

Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogeneticsDONGXIAO SUN; GANG CHEN; DELLINGER, Ryan W et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 10, pp 575-585, issn 1744-6872, 11 p.Article

Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifenRIVERA, Edgardo; VALERO, Vicente; FRANCIS, Deborah et al.Clinical cancer research. 2004, Vol 10, Num 6, pp 1943-1948, issn 1078-0432, 6 p.Article

The use of aromatase inhibitors in adjuvant therapy for early breast cancerJONAT, Walter; HILPERT, Felix; MAASS, Nicolai et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, issn 0344-5704, s32-s38, SUP1Article

Overview of adjuvant trials of aromatase inhibitors in early breast cancerINGLE, James N.Steroids. 2011, Vol 76, Num 8, pp 765-767, issn 0039-128X, 3 p.Conference Paper

Development and validation of a stability indicating LC method for the assay and related substances determination of Exemestane, an aromatase inhibitorSURESH KUMAR, R; NARASIMHA NAIDU, M; SRINIVASULU, Kasa et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 50, Num 5, pp 746-752, issn 0731-7085, 7 p.Article

A feasibility study of the efficacy and tolerability of the combination of exemestane with the COX-2 inhibitor celecoxib in post-menopausal patients with advanced breast cancerCANNEY, P. A; MACHIN, M. A; CURTO, J et al.European journal of cancer (1990). 2006, Vol 42, Num 16, pp 2751-2756, issn 0959-8049, 6 p.Article

Effects of adjuvant aromatase inhibitor therapy on lipid profilesMONNIER, Alain.Expert review of anticancer therapy. 2006, Vol 6, Num 11, pp 1653-1662, issn 1473-7140, 10 p.Article